← Leaderboards
Lichong Xu
Pennsylvania State Univ Hershey Med Ctr
$1,722,875
Attributed
$1,722,875
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $657.2K · FY2018–25$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,722,875 · 2
By mechanism
R01$1,310,558 · 1
R21$412,317 · 1
Top collaborators
No co-investigators on record.
Most similar at Pennsylvania State Univ Hershey Med Ctr
Same institution · by research overlap
- Christopher A Siedlecki$7,714,397
- Choon-Sik Jhun$2,721,006
- Marnie M. Saunders$913,083
Others in their field
Other Emerging Leaders on “Bacteria”
- Urs Ochsner · Crestone, Inc.$40,390,611
- Ryan Cirz · Revagenix, Inc.$35,410,554
- Daniel Pevear · Venatorx Pharmaceuticals, Inc.$24,789,028
- Gary Fanger · Rise Therapeutics, Llc$19,697,313
- Bruce Blough · Research Triangle Institute$19,637,160
- Thomas Dick · Rbhs-New Jersey Medical School$14,299,891
Research focus
BacteriaMolecularPolyurethanesPolymersResponseBacterial AdhesionMicrobial BiofilmsMicrobialModificationPathogenicityPropertyResearch PrioritySurfaceBiocompatible MaterialsInfectionImplantIn VitroMedical DeviceAnti-Bacterial AgentsCathetersHemocompatibilityBasic ScienceAntibiotic TherapyBase
Grant awards (4)
Antimicrobial Biomaterials that Interfere with Bacterial Nucleotide Messenger Signaling$657,241
R01 · FY2025 · AI · contact PI
Antimicrobial Biomaterials that Interfere with Bacterial Nucleotide Messenger Signaling$653,317
R01 · FY2024 · AI · contact PI
Textured Polyphosphazene Biomaterial with Improved Hemocompatibility$192,326
R21 · FY2019 · AI · contact PI
Textured Polyphosphazene Biomaterial with Improved Hemocompatibility$219,991
R21 · FY2018 · AI · contact PI